Angela Hernandez
Apr 12, 2012

Kinase test has potential to combat drug-resistant cancers

A team at the University of North Carolina introduced the first broad-based test for activation of protein kinases, allowing measurement of the mechanism behind drug-resistant cancer and prediction of successful combination therapies. Kinases are proteins expressed in human tissues that are involved in cell growth, particularly in cancer. About 400 out of 518 known human kinases are expressed in cancers but which ones and how many are active in tumors has been difficult to measure. The team has developed a test that can measure the presence and activity of 60-70 percent of all kinases, enabling investigators to see how cancers resist treatment with kinase inhibitors.

Companies
1
Patents
1
0 Comments
Related Articles
Elisabeth Manville
Mar 19, 2012
Genetic variant responsible for resistance to cancer drugs in some patients of East Asian descent
A research team led by scientists at Duke-NUS Graduate Medical School in Singapore have identified a genetic variation that causes... Read More
BRAF-mutated metastatic melanoma patients with second mutation do not show increased drug resistance
Scientists at the University of California, Los Angeles have discovered that a second mutation found in the tumors of patients... Read More
Angela Hernandez
Apr 12, 2012
Biomarkers found for chemotherapy resistance in breast cancer
Researchers at the University of Hull have identified biomarkers which could help to predict resistance to chemotherapy in breast cancer... Read More